Nav1.7 is essential for nociceptor action potentials in the mouse in a manner independent of endogenous opioids

[1]  S. McMahon,et al.  Examination of the contribution of Nav1.7 to axonal propagation in nociceptors. , 2021, Pain.

[2]  D. Henze,et al.  Nav1.7 target modulation and efficacy can be measured in nonhuman primate assays , 2021, Science Translational Medicine.

[3]  F. Zufall,et al.  A central mechanism of analgesia in mice and humans lacking the sodium channel NaV1.7 , 2021, Neuron.

[4]  G. King,et al.  Fifteen years of NaV1.7 channels as an analgesic target: Why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy? , 2020, British journal of pharmacology.

[5]  D. Kohane,et al.  Polymer-tetrodotoxin conjugates to induce prolonged duration local anesthesia with minimal toxicity , 2019, Nature Communications.

[6]  M. Rothenberg,et al.  Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers , 2019, Clinical Drug Investigation.

[7]  D. Hackos,et al.  Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors , 2018, The Journal of Neuroscience.

[8]  D. Sutherlin,et al.  Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain. , 2018, Cell reports.

[9]  Ben Sidders,et al.  Network-Based Drug Discovery: Coupling Network Pharmacology with Phenotypic Screening for Neuronal Excitability. , 2018, Journal of molecular biology.

[10]  Brian E Marron,et al.  Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes. , 2017, Bioorganic & medicinal chemistry letters.

[11]  Dong Liu,et al.  Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7 , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[12]  J. Wood,et al.  Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice , 2017, Science Signaling.

[13]  Jun-Ming Zhang,et al.  Localized Sympathectomy Reduces Mechanical Hypersensitivity by Restoring Normal Immune Homeostasis in Rat Models of Inflammatory Pain , 2016, The Journal of Neuroscience.

[14]  Jun Li,et al.  Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist , 2015, Science.

[15]  Flavia Mancini,et al.  Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7 , 2015, Nature Communications.

[16]  H. Hioki,et al.  Dorsal Horn Circuits for Persistent Mechanical Pain , 2015, Neuron.

[17]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[18]  S. Linnarsson,et al.  Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing , 2014, Nature Neuroscience.

[19]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[20]  A. Winterpacht,et al.  Inherited Pain , 2013, The Journal of Biological Chemistry.

[21]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[22]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[23]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[24]  S. Waxman,et al.  Membrane properties and electrogenesis in the distal axons of small dorsal root ganglion neurons in vitro. , 2012, Journal of neurophysiology.

[25]  S. Dib-Hajj,et al.  Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy , 2012, Annals of neurology.

[26]  Wenqin Luo,et al.  The Functional Organization of Cutaneous Low-Threshold Mechanosensory Neurons , 2011, Cell.

[27]  S. Dib-Hajj,et al.  Sodium channels in normal and pathological pain. , 2010, Annual review of neuroscience.

[28]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[29]  S. Dib-Hajj,et al.  Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation. , 2009, Brain : a journal of neurology.

[30]  S. Dib-Hajj,et al.  NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders , 2008, The Journal of Neuroscience.

[31]  Yi Dai,et al.  Comparative study of the distribution of the α‐subunits of voltage‐gated sodium channels in normal and axotomized rat dorsal root ganglion neurons , 2008, The Journal of comparative neurology.

[32]  S. Dib-Hajj,et al.  Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable , 2008, Molecular pain.

[33]  M. Dubé,et al.  Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations , 2007, Clinical genetics.

[34]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[35]  D. Kohane,et al.  Tetrodotoxin for prolonged local anesthesia with minimal myotoxicity , 2006, Muscle & nerve.

[36]  A. M. Rush,et al.  A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Sulayman D. Dib-Hajj,et al.  Electrophysiological Properties of Mutant Nav1.7 Sodium Channels in a Painful Inherited Neuropathy , 2004, The Journal of Neuroscience.

[38]  R. Langer,et al.  A Re‐examination of Tetrodotoxin for Prolonged Duration Local Anesthesia , 1998, Anesthesiology.

[39]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[40]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[41]  OUP accepted manuscript , 2021, Brain.

[42]  D. Hackos,et al.  Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7. , 2018, Handbook of experimental pharmacology.

[43]  S. Waxman,et al.  Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents. , 2014, Handbook of experimental pharmacology.

[44]  S. Dib-Hajj,et al.  Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons , 2011, Nature Reviews Neurology.

[45]  A. Hodgkin,et al.  A quantitative description of membrane current and its application to conduction and excitation in nerve , 1990, Bulletin of mathematical biology.